These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

865 related articles for article (PubMed ID: 21586712)

  • 21. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.
    Johnson DA; Orr WC; Crawley JA; Traxler B; McCullough J; Brown KA; Roth T
    Am J Gastroenterol; 2005 Sep; 100(9):1914-22. PubMed ID: 16128933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Long-term treatment of patients with symptomatic gastroesophageal reflux disease comparing costs and efficacy over 6 months of treatment with Nexium On-Demand Treatment or Nexium continuous treatment. An open, randomised multi-center study].
    Beglinger C; Thalmann C; Szucs T; Michetti P
    Praxis (Bern 1994); 2006 Mar; 95(13):483-7. PubMed ID: 16602668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Postprandial Administration of Esomeprazole on Reflux Symptoms in Gastroesophageal Reflux Disease: A Randomized, Controlled Trial.
    Boltin D; Zvidi I; Raskin M; Kayless H; Schmilovitz-Weiss H; Gingold-Belfer R; Niv Y; Dickman R
    Dig Dis; 2018; 36(4):257-263. PubMed ID: 29791895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of laparoscopic antireflux surgery on belching in pediatric GERD patients.
    Rinsma NF; Mauritz FA; van Heurn LW; Sloots CE; Siersema PD; Houwen RH; van der Zee DC; Masclee AA; Conchillo JM; Van Herwaarden-Lindeboom MY
    Neurogastroenterol Motil; 2016 Oct; 28(10):1525-32. PubMed ID: 27151185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1-24 months old with symptoms of gastroesophageal reflux disease.
    Omari T; Davidson G; Bondarov P; Nauclér E; Nilsson C; Lundborg P
    J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):530-7. PubMed ID: 18030229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease.
    Lundell L; Miettinen P; Myrvold HE; Pedersen SA; Liedman B; Hatlebakk JG; Julkonen R; Levander K; Carlsson J; Lamm M; Wiklund I
    J Am Coll Surg; 2001 Feb; 192(2):172-9; discussion 179-81. PubMed ID: 11220717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptomatic outcomes of laparoscopic antireflux surgery in patients eligible for endoluminal therapies.
    Desai KM; Klingensmith ME; Winslow ER; Frisella P; Soper NJ
    Surg Endosc; 2002 Dec; 16(12):1669-73. PubMed ID: 12140637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies.
    Attwood SE; Ell C; Galmiche JP; Fiocca R; Hatlebakk JG; Hasselgren B; Långström G; Jahreskog M; Eklund S; Lind T; Lundell L
    Aliment Pharmacol Ther; 2015 Jun; 41(11):1162-74. PubMed ID: 25858519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoscopic stapling in comparison to laparoscopic fundoplication for the treatment of gastroesophageal reflux disease.
    Danalioglu A; Cipe G; Toydemir T; Kocaman O; Ince AT; Muslumanoglu M; Senturk H
    Dig Endosc; 2014 Jan; 26(1):37-42. PubMed ID: 23560891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan.
    Sakurai K; Suda H; Fujie S; Takeichi T; Okuda A; Murao T; Hasuda K; Hirano M; Ito K; Tsuruta K; Hattori M
    Dig Dis Sci; 2019 Mar; 64(3):815-822. PubMed ID: 30415407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of life convergence of laparoscopic and open anti-reflux surgery for gastroesophageal reflux disease.
    Violette A; Velanovich V
    Dis Esophagus; 2007; 20(5):416-9. PubMed ID: 17760656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laparoscopic antireflux surgery for refractory gastroesophageal reflux disease: long-term clinical outcomes.
    Ugliono E; Rebecchi F; Mantova S; Osella G; Mansour AMFMH; Morino M
    Updates Surg; 2023 Jun; 75(4):979-986. PubMed ID: 36862352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptom-relieving effect of esomeprazole 40 mg daily in patients with heartburn.
    Johnsson F; Hatlebakk JG; Klintenberg AC; Román J
    Scand J Gastroenterol; 2003 Apr; 38(4):347-53. PubMed ID: 12739705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five-year follow-up of a multicenter, double-blind randomized clinical trial of laparoscopic Nissen vs anterior 90 degrees partial fundoplication.
    Nijjar RS; Watson DI; Jamieson GG; Archer S; Bessell JR; Booth M; Cade R; Cullingford GL; Devitt PG; Fletcher DR; Hurley J; Kiroff G; Martin IJ; Nathanson LK; Windsor JA;
    Arch Surg; 2010 Jun; 145(6):552-7. PubMed ID: 20566975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of pantoprazole 20 mg daily compared with esomeprazole 20 mg daily in the maintenance of healed gastroesophageal reflux disease: a randomized, double-blind comparative trial - the EMANCIPATE study.
    Goh KL; Benamouzig R; Sander P; Schwan T;
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):205-11. PubMed ID: 17301646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomised prospective study comparing the effectiveness of esomeprazole treatment strategies in clinical practice for 6 months in the management of patients with symptoms of gastroesophageal reflux disease.
    Norman Hansen A; Bergheim R; Fagertun H; Lund H; Moum B
    Int J Clin Pract; 2005 Jun; 59(6):665-71. PubMed ID: 15924594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia.
    Moawad FJ; Veerappan GR; Dias JA; Baker TP; Maydonovitch CL; Wong RK
    Am J Gastroenterol; 2013 Mar; 108(3):366-72. PubMed ID: 23399553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On-demand versus half-dose continuous therapy with esomeprazole for maintenance treatment of gastroesophageal reflux disease: A randomized comparative study.
    Cho JH; Koo JY; Kim KO; Lee SH; Jang BI; Kim TN
    Medicine (Baltimore); 2018 Oct; 97(43):e12732. PubMed ID: 30412065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams.
    Devault KR; Johanson JF; Johnson DA; Liu S; Sostek MB
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):852-9. PubMed ID: 16682260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
    Haag S; Holtmann G
    Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.